Target Name: TANGO2
NCBI ID: G128989
Review Report on TANGO2 Target / Biomarker Content of Review Report on TANGO2 Target / Biomarker
TANGO2
Other Name(s): MECRCN | transport and golgi organization 2 homolog | TANGO2 variant 2 | Transport and golgi organization 2 homolog, transcript variant 15 | Transport and Golgi organization protein 2 homolog (isoform b) | Transport and Golgi organization protein 2 homolog, transcript variant X16 | Transport and golgi organization 2 homolog, transcript variant 4 | TANGO2 variant 4 | Transport and Golgi organization protein 2 homolog isoform X6 | C22orf25 | TANGO2 variant 1 | TNG2_HUMAN | Transport and golgi organization 2 homolog, transcript variant 2 | TANGO2 variant 15 | Transport and Golgi organization protein 2 homolog | TANGO2 variant X16 | transport and Golgi organization protein 2 homolog | Transport and Golgi organization protein 2 homolog (isoform a) | Transport and Golgi organization protein 2 homolog isoform i | Transport and golgi organization 2 homolog, transcript variant 1

TANGO2: A Protein Involved in Cell Survival, Migration and Inflammation

TANGO2 (TanGO2-containing protein 2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the TANGO2 family, which is known for its role in regulating gene expression and cell-cell signaling. TANGO2 has been shown to play a role in a variety of physiological processes, including cell survival, migration, and inflammation. As a result, TANGO2 has been identified as a potential drug target and a biomarker for a variety of diseases.

The TANGO2 family of proteins was first identified in the 1990s by researchers who were studying the role of gene expression in the development of cancer. They found that many cancer cells had altered levels of TANGO2, and that this was associated with the development of cancer. Since then, studies have continued to explore the functions of TANGO2 and its role in various physiological processes.

One of the key functions of TANGO2 is its role in cell survival. TANGO2 has been shown to play a role in regulating the survival of brain cells, heart muscle cells, and other types of cells. It does this by helping to maintain the structural and functional integrity of these cells, and by preventing them from undergoing apoptosis (programmed cell death). This is important for maintaining the health and function of tissues throughout the body, and is therefore of great interest for the development of strategies for preventing or treating a variety of diseases.

Another function of TANGO2 is its role in cell migration. TANGO2 has been shown to play a role in the migration of cells, both in the development of cancer and in the regulation of normal tissue growth and development. This is important for the development of new treatments for diseases such as cancer, as well as for the maintenance of tissues and organs in the body.

In addition to its roles in cell survival and migration, TANGO2 is also involved in the regulation of inflammation. TANGO2 has been shown to play a role in the regulation of immune responses, and is therefore of interest for the development of new treatments for autoimmune diseases.

As a result of its involvement in these processes, TANGO2 has been identified as a potential drug target and biomarker for a variety of diseases. For example, studies have shown that TANGO2 is highly expressed in various types of cancer, and that inhibiting its activity may be an effective way to treat these diseases. Similarly, TANGO2 has been shown to be involved in the regulation of cell migration, and that alterations in its activity may be a cause of the migration of cancer cells to new tissues.

In conclusion, TANGO2 is a protein that is expressed in various tissues of the body and is involved in a variety of physiological processes. Its role in cell survival, migration, and inflammation makes it an attractive target for drug development and research into the development and progression of various diseases. Further studies are needed to fully understand the functions of TANGO2 and its potential as a drug target and biomarker.

Protein Name: Transport And Golgi Organization 2 Homolog

The "TANGO2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TANGO2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TANGO6 | TANK | Tankyrase | TAOK1 | TAOK2 | TAOK3 | TAP1 | TAP2 | TAPBP | TAPBPL | TAPT1 | TAPT1-AS1 | TARBP1 | TARBP2 | TARDBP | TARDBPP1 | TARDBPP3 | TARID | TARM1 | TARP | TARS1 | TARS2 | TARS3 | TAS1R1 | TAS1R2 | TAS1R3 | TAS2R1 | TAS2R10 | TAS2R13 | TAS2R14 | TAS2R16 | TAS2R19 | TAS2R20 | TAS2R3 | TAS2R30 | TAS2R31 | TAS2R38 | TAS2R39 | TAS2R4 | TAS2R40 | TAS2R41 | TAS2R42 | TAS2R43 | TAS2R45 | TAS2R46 | TAS2R5 | TAS2R50 | TAS2R60 | TAS2R63P | TAS2R64P | TAS2R7 | TAS2R8 | TAS2R9 | TASL | TASOR | TASOR2 | TASP1 | Taste receptor type 2 | Taste Receptors Type 1 | TAT | TAT-AS1 | TATDN1 | TATDN2 | TATDN2P3 | TATDN3 | TAX1BP1 | TAX1BP3 | TBATA | TBC1D1 | TBC1D10A | TBC1D10B | TBC1D10C | TBC1D12 | TBC1D13 | TBC1D14 | TBC1D15 | TBC1D16 | TBC1D17 | TBC1D19 | TBC1D2 | TBC1D20 | TBC1D21 | TBC1D22A | TBC1D22A-AS1 | TBC1D22B | TBC1D23 | TBC1D24 | TBC1D25 | TBC1D26 | TBC1D27P | TBC1D28 | TBC1D29P | TBC1D2B | TBC1D3 | TBC1D30 | TBC1D31 | TBC1D32 | TBC1D3B | TBC1D3C | TBC1D3F